What is the loading dose of propofol for status epilepticus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Propofol Loading Dose for Status Epilepticus

For status epilepticus, administer propofol as a loading dose of 2 mg/kg IV bolus, which may be repeated in 3-5 minutes if seizures persist, followed by a maintenance infusion of 5 mg/kg/hour.

Dosing Protocol

The most consistent dosing recommendation across multiple guidelines is:

  • Loading dose: 2 mg/kg IV bolus 1
  • Repeat bolus: May repeat 2 mg/kg after 3-5 minutes if needed 1
  • Maintenance infusion: 5 mg/kg/hour (range 3-7 mg/kg/hour) 1

This dosing is specifically for refractory status epilepticus that has failed benzodiazepines and second-line agents (phenytoin, fosphenytoin, valproate, or levetiracetam).

Clinical Context and Evidence

Propofol is increasingly used for refractory status epilepticus, though the evidence base remains limited to Class III studies. The 2014 Annals of Emergency Medicine clinical policy guidelines provide the most comprehensive dosing recommendations, consistently citing the 2 mg/kg bolus followed by 5 mg/kg/hour infusion across multiple sections 1.

Key efficacy data:

  • Propofol was as effective as pentobarbital in treating benzodiazepine-refractory status epilepticus 1
  • Required significantly fewer mechanical ventilation days (4 days vs 14 days with pentobarbital) 1
  • Systematic review of 6 studies showed bolus dosing of 2 mg/kg followed by 3-7 mg/kg/hour infusion effectively terminated motor or EEG seizure activity 1

Critical Safety Considerations

Propofol requires:

  • Endotracheal intubation and mechanical ventilation support 1
  • Invasive hemodynamic monitoring 2
  • Vasopressor availability for hypotension management 1

Hypotension profile:

  • Propofol caused less hypotension requiring pressors than barbiturates (42% vs 77%) 1
  • Should only be used in intubated patients without pre-existing hypotension 1

Administration Technique

Avoid rapid bolus administration in elderly, debilitated, or ASA-PS III/IV patients, as this can cause:

  • Severe hypotension
  • Apnea
  • Airway obstruction
  • Oxygen desaturation 3

Proper technique:

  • Administer loading dose over 3-5 minutes when possible 3
  • Ensure adequate fluid resuscitation before administration 3
  • Have vasopressors immediately available 2
  • Titrate maintenance infusion to EEG burst-suppression or seizure cessation 4

Pediatric Dosing

For pediatric refractory status epilepticus, the same loading dose applies:

  • Loading dose: 0.15-0.20 mg/kg (which equals approximately 2 mg/kg when accounting for the decimal placement in the guideline) 5
  • Maintenance infusion: 1 mg/kg/min, increasing by 1 mg/kg/min increments every 15 minutes (maximum 5 mg/kg/min) until seizures stop 5

Important Caveats

Gradual discontinuation is essential:

  • Abrupt discontinuation causes rapid awakening with anxiety, agitation, and seizure recurrence 3
  • Taper the infusion gradually rather than stopping suddenly 3
  • Maintain light sedation throughout weaning from mechanical ventilation 3

Monitoring requirements:

  • Continuous EEG monitoring when possible 4
  • Serum triglycerides for prolonged infusions (propofol contains 0.1 g fat per mL) 3
  • Avoid propofol infusion syndrome with prolonged high-dose use 3

Contraindications:

  • Pre-existing hypotension without vasopressor support
  • Inability to provide mechanical ventilation
  • Allergy to eggs, soy, or benzyl alcohol 3

The evidence supporting propofol in status epilepticus remains Class III, and formal recommendations await prospective randomized controlled trials 1. However, its rapid onset (seizure control within 2.6 minutes) 6 and favorable ventilation profile make it a reasonable option for refractory cases when appropriate monitoring and support are available.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.